Novo Nordisk Parent Resubmits Catalent Deal Application to FTC
Novo Nordisk’s parent company, Novo Nordisk Foundation, has refiled its application to the U.S. Federal Trade Commission (FTC) seeking approval for its $1... Read more.
Appeals Court Upholds Dismissal: Parents’ Claims Over Abbott Formula Price Dismissed
The 7th U.S. Circuit Court of Appeals has affirmed the dismissal of a proposed class action lawsuit brought by parents who alleged they had overpaid for Abbott ... Read more.
FDA Greenlights Vanda Pharmaceuticals’ Bipolar Disorder Drug: Fanapt Approved for Manic Episodes
Vanda Pharmaceuticals Inc. celebrated a significant milestone as the U.S. Food and Drug Administration (FDA) granted approval for its groundbreaking medication ... Read more.
AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Potential Contamination: What Consumers Need to Know
AvKARE, LLC has initiated a voluntary recall of Atovaquone Oral Suspension, USP 750 mg/5 mL, lot # AW0221A, due to potential Bacillus cereus contamination. This... Read more.
Revived Patent Challenge: Teva and Viatris Poised to Shake Up Schizophrenia Drug Market
In a recent development, Teva Pharmaceutical Industries Ltd and Viatris Inc have successfully persuaded a U.S. appeals court to revive their challenges against ... Read more.
Mastery of Precision: The Fill and Finish Service in Biologic Drug Production
The fill and finish service in biologic drug production encapsulates the confluence of precision, technology, and stringent quality control, ensuring that each ... Read more.
Revolutionizing Healthcare Awareness Through Educational Innovation
Picture Credit In an age where information matters, how we impart knowledge is crucial. There has been a significant transformation in educational methodologies... Read more.
Kobayashi Pharmaceutical To Withdraw Red Yeast Rice Capsules From The Market After 2 Two Fatalities
The Japanese health authorities have taken swift action by ordering Kobayashi Pharmaceutical (4967.T) to recall three dietary supplement products containing red... Read more.
U.S. FDA Approves Akebia’s Vadadustat For CKD-induced Anemia
On March 27, the U.S. Food and Drug Administration (FDA) granted approval to Akebia Therapeutics’ (AKBA.O) drug, vadadustat, for the treatment of anemia r... Read more.
US FDA Approves Merck’s Winrevair for Rare Lung Condition
The U.S. Food and Drug Administration’s recent approval of Merck’s (MRK.N) treatment for adults suffering from high blood pressure due to constricti... Read more.